These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors. Kahn D; Silver JM; Opler LA J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181 [TBL] [Abstract][Full Text] [Related]
24. Tyramine and new monoamine oxidase inhibitor drugs. Simpson GM; de Leon J Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125 [TBL] [Abstract][Full Text] [Related]
25. Potential adverse effects of discontinuing psychotropic drugs: part 2: antidepressant drugs. Howland RH J Psychosoc Nurs Ment Health Serv; 2010 Jul; 48(7):9-12. PubMed ID: 20608581 [TBL] [Abstract][Full Text] [Related]
26. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases]. Oostervink F; Bouvy PF; Touw DJ Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773 [TBL] [Abstract][Full Text] [Related]
27. Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review. Parker G; Mitchell P; Wilhelm K; Menkes D; Snowdon J; Schweitzer I; Grounds D; Skerritt P; Roy K; Hadzi-Pavlovic D Aust N Z J Psychiatry; 1999 Dec; 33(6):874-81. PubMed ID: 10619215 [TBL] [Abstract][Full Text] [Related]
28. Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam. Naylor MW; Grunhaus L; Cameron O J Nerv Ment Dis; 1987 Feb; 175(2):111-4. PubMed ID: 3806075 [TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy in older depressed patients. Fann WE J Gerontol; 1976 May; 31(3):304-10. PubMed ID: 5482 [TBL] [Abstract][Full Text] [Related]
30. Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant Depression. Amsterdam JD; Kim TT J Clin Psychopharmacol; 2019; 39(6):649-652. PubMed ID: 31688401 [TBL] [Abstract][Full Text] [Related]
31. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Thomas SJ; Shin M; McInnis MG; Bostwick JR Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531 [TBL] [Abstract][Full Text] [Related]
32. Induction of obesity by psychotropic drugs. Bernstein JG Ann N Y Acad Sci; 1987; 499():203-15. PubMed ID: 2886102 [TBL] [Abstract][Full Text] [Related]
33. Psychotherapeutic drugs: important adverse reactions and interactions. Burrows GD; Norman TR Drugs; 1980 Dec; 20(6):485-93. PubMed ID: 6110534 [No Abstract] [Full Text] [Related]
34. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Kline SS; Mauro LS; Scala-Barnett DM; Zick D Clin Pharm; 1989 Jul; 8(7):510-4. PubMed ID: 2568897 [No Abstract] [Full Text] [Related]
36. [Combining a classic monoamine oxidase inhibitor with a tricyclic antidepressant in therapy-resistant depression: a case report and literature review]. Schipper P; Vanmolkot L; Peeters FP Tijdschr Psychiatr; 2016; 58(12):886-890. PubMed ID: 27976787 [TBL] [Abstract][Full Text] [Related]
37. [The risk of neuroleptic discontinuation in schizophrenia]. Jarema M Psychiatr Pol; 1999; 33(1):69-81. PubMed ID: 10786216 [TBL] [Abstract][Full Text] [Related]
38. Drugs for psychiatric disorders. Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519 [No Abstract] [Full Text] [Related]
39. The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants. Davidson J; Pelton S; Krishnan RR; Allf B J Affect Disord; 1986; 11(1):51-8. PubMed ID: 2944928 [TBL] [Abstract][Full Text] [Related]